Hetrombopag olamine: all 24 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingNCT07286032Phase 3
- Herombopag Treated T-DM1 Induced Platelet ReductionRecruitingNCT07257809Phase 2
- A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingNCT07252375Phase 2
- Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyNot yet recruitingNCT07243418Phase 2
- A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPRecruitingNCT06838949Phase 2
- TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingNCT06478537Phase 2
- Hetrombopag for the Thrombocytopenia Induced by Concurrent ChemoradiotherapyRecruitingNCT06433830Phase 2
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.Not yet recruitingNCT06346925Phase 1
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy SubjectsNot yet recruitingNCT06062680Phase 1
- Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid LeukemiaNot yet recruitingNCT05944211Phase 2
- Herombopag Olamine in the Treatment of Thrombocytopenia After ChemotherapyStatus unknownNCT05575986Phase 4
- An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownNCT05252091Phase 2
- A Bioequivalence Study of Hetrombopag in Healthy SubjectsCompletedNCT05088655Phase 1
- A Trial of Hetrombopag in Healthy and Hepatic Impairment SubjectsCompletedNCT05088642Phase 1
- Extension Study of Hetrombopag in Severe Aplastic AnemiaActive, not recruitingNCT04961710Phase 3
- Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human SubjectsCompletedNCT03977805Phase 1
- Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaCompletedNCT03825744Phase 3
- A Study to Evaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsCompletedNCT03603132Phase 1
- A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） PatientCompletedNCT03557099Phase 1/2
- Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) PatientCompletedNCT03222843Phase 3
- Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02614846Phase 1
- Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy SubjectsCompletedNCT02409394Phase 1
- A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02403440Phase 1
- A Phase I Study of Hetrombopag Olamine in Healthy Adult VolunteersCompletedNCT01830660Phase 1